Baird Maintains Applied Therapeutics(APLT.US) With Buy Rating, Maintains Target Price $14

Futu NewsNov 21 15:32 · Ratings

Positive Regulatory Outlook and Imminent PDUFA Date Justify Buy Rating for Applied Therapeutics

TipRanksNov 11 14:29 · Ratings

RBC Capital Maintains Applied Therapeutics(APLT.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 9 10:32 · Ratings

Applied Therapeutics Advances With Govorestat Approvals

TipRanksNov 8 13:59

Applied Therapeutics GAAP EPS of -$0.48, Revenue of $0.12M

Seeking AlphaNov 7 22:35

Applied Therapeutics (APLT) Gets a Buy From William Blair

TipRanksNov 7 22:07 · Ratings